Rhythm Pharmaceuticals Inc (RYTM)

Rhythm Pharmaceuticals Inc Stock (RYTM) Financials Data

*All numbers in millions

Period End Date	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	18.54%71.26	60.11	57.25	51.30	48.50
Cost Of Revenue	24.79%8.93	7.16	4.80	5.50	5.54
	6.07%67.45	63.59	-	-	-
Selling, General, and Administrative	6.07%67.45	63.59	-	-	-
Research and Development	4.08%43.43	41.73	-	-	-
Costs And Expenses	6.52%119.81	112.47	104.32	103.95	93.80
Operating Income/Loss	7.27%-48.55	-52.36	-47.06	-52.65	-45.30
Nonoperating Income/Loss	88.95%-0.30	-2.73	-0.47	-0.14	-1.00
Income/Loss From Continuing Operations Before Tax	11.33%-48.85	-55.09	-47.54	-52.79	-46.30
Income Tax Expense/Benefit	18.53%0.44	0.55	-0.03	0.11	0.34
	11.40%-49.30	-55.64	-47.51	-52.90	-46.63
Attributable To Parent	11.40%-49.30	-55.64	-47.51	-52.90	-46.63
Available To Common Stockholders, Basic	11.24%-50.36	-56.74	-48.84	-54.28	-47.98
Basic Average Shares	0.91%68.59	67.97	0.64	66.26	63.68
Diluted Average Shares	0.91%68.59	67.97	0.64	66.26	63.68
Basic Earnings Per Share	12.05%-0.73	-0.83	-0.73	-0.82	-0.75
Diluted Earnings Per Share	12.05%-0.73	-0.83	-0.73	-0.82	-0.75